<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 2.3: Osteoporosis Pathophysiology and Screening Standards</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/GOLD theme for Vascular & Bone */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #3b82f6;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table Styling */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f1f5f9;
            padding: 15px;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e2e8f0;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #ffffff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 50px 0;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: repeat(2, 1fr); }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 2: Vascular & Bone Integrity (VITAL)</p>
            <h1 class="lesson-title">Lesson 2.3: Osteoporosis Pathophysiology and Screening Standards</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 3 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Silent Skeleton Epidemic</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Estrogen-Bone Nexus</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Bone Remodeling Mechanisms</a></li>
                <li><a href="#section4"><span class="section-num">4</span>DXA Screening Standards</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Interpreting T-Scores</a></li>
                <li><a href="#section6"><span class="section-num">6</span>FRAX: Assessing Clinical Risk</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the cellular mechanism of how estrogen deficiency accelerates bone resorption.</li>
                <li>Identify the clinical difference between T-scores and Z-scores in post-menopausal screening.</li>
                <li>Differentiate between normal bone density, osteopenia, and osteoporosis using WHO criteria.</li>
                <li>Describe the "Rapid Bone Loss" phase occurring in the first five years of menopause.</li>
                <li>Utilize the FRAX tool to predict 10-year fracture probability for high-risk clients.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>Mastering Skeletal Longevity</h3>
            <p>In the VITAL Methodâ„¢, the 'V' stands for Vascular & Bone Integrity. While cardiovascular health is often the "sudden" killer, osteoporosis is the "silent" disabler. As a Menopause Support Coach, your ability to understand the cellular breakdown of bone and the nuances of screening reports is vital for preventing fractures that often lead to a permanent loss of independence in later life.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Osteoclast</p>
                    <p class="definition">Specialized bone cells that break down and resorb bone tissue by secreting acid and proteases.</p>
                </div>
                <div class="term-item">
                    <p class="term">Osteoblast</p>
                    <p class="definition">Cells responsible for bone formation; they lay down the collagen matrix and minerals.</p>
                </div>
                <div class="term-item">
                    <p class="term">RANKL</p>
                    <p class="definition">A protein that binds to osteoclasts, signaling them to start breaking down bone. Estrogen normally suppresses this.</p>
                </div>
                <div class="term-item">
                    <p class="term">T-Score</p>
                    <p class="definition">A comparison of a patient's bone density to that of a healthy 30-year-old of the same sex.</p>
                </div>
                <div class="term-item">
                    <p class="term">Resorption</p>
                    <p class="definition">The process by which bone is dissolved and minerals are released into the blood.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The Silent Skeleton Epidemic</h2>
        <p>Osteoporosis is characterized by low bone mass and micro-architectural deterioration of bone tissue, leading to enhanced bone fragility. For many women, the first "symptom" of osteoporosis is a fractureâ€”often of the wrist, hip, or spine. This is why it is frequently called the <span class="highlight">"Silent Disease."</span></p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">1 in 2</div>
                    <div class="stat-label">Women over 50 with Fractures</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">20%</div>
                    <div class="stat-label">Bone Loss in 5 Years</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2.5X</div>
                    <div class="stat-label">Risk Increase Post-Menopause</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">24%</div>
                    <div class="stat-label">Mortality Rate after Hip Fracture</div>
                </div>
            </div>
        </div>

        <p>A 2022 meta-analysis involving over 1.2 million women confirmed that the <span class="highlight">incidence of osteoporosis increases fivefold</span> within the first decade after the final menstrual period. This isn't just a gradual aging process; it is a metabolic shift triggered by the withdrawal of 17Î²-estradiol.</p>

        <h2 id="section2">The Estrogen-Bone Nexus</h2>
        <p>Estrogen is the primary "protector" of the skeletal system. In a pre-menopausal state, estrogen maintains a delicate balance between bone formation (osteoblasts) and bone resorption (osteoclasts). It achieves this through several pathways:</p>
        
        <ul class="content-list">
            <li><strong>Suppression of Cytokines:</strong> Estrogen inhibits the production of pro-inflammatory cytokines like IL-1, IL-6, and TNF-alpha, which are known to stimulate osteoclast activity.</li>
            <li><strong>The RANKL/OPG Pathway:</strong> Estrogen increases the production of <em>Osteoprotegerin (OPG)</em>, a "decoy" receptor that prevents RANKL from binding to osteoclasts. When estrogen drops, OPG drops, and RANKL runs rampant.</li>
            <li><strong>Osteocyte Survival:</strong> Estrogen prevents the apoptosis (programmed cell death) of osteocytes, the "sensor" cells that tell the bone where it needs to be strengthened.</li>
        </ul>

        <div class="alert-box warning">
            <p class="alert-label">The "Rapid Loss" Phase</p>
            <p>During the trans-menopause period (the year before and the two years after the final period), bone resorption speeds up significantly. Research shows women can lose up to <span class="highlight">3-5% of their bone density per year</span> during this narrow window, compared to 0.5% per year in late post-menopause.</p>
        </div>

        <h2 id="section3">Bone Remodeling Mechanisms</h2>
        <p>Bone is a living tissue that is constantly being recycled. This process is called <strong>remodeling</strong>. In a healthy adult, approximately 10% of the skeleton is replaced every year. However, in the absence of estrogen, the "recycling" becomes "demolition."</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Pre-Menopause</th>
                        <th>Post-Menopause (No HRT)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Remodeling Rate</strong></td>
                        <td>Balanced (Coupled)</td>
                        <td>High Turnover (Uncoupled)</td>
                    </tr>
                    <tr>
                        <td><strong>Osteoclast Life-span</strong></td>
                        <td>Short (Apoptosis regulated)</td>
                        <td>Extended (More resorption)</td>
                    </tr>
                    <tr>
                        <td><strong>Trabecular Bone</strong></td>
                        <td>Thick and connected</td>
                        <td>Thinning and perforated</td>
                    </tr>
                    <tr>
                        <td><strong>Calcium Absorption</strong></td>
                        <td>Efficient intestinal uptake</td>
                        <td>Reduced; secondary hyperparathyroidism</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">DXA Screening Standards</h2>
        <p>The gold standard for diagnosing osteoporosis is <span class="highlight">Dual-Energy X-ray Absorptiometry (DXA)</span>. DXA measures Bone Mineral Density (BMD) at specific sites, typically the lumbar spine, total hip, and femoral neck. These sites are chosen because they contain high amounts of trabecular (spongy) bone, which is more metabolically active and sensitive to estrogen loss.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Healthy" Runner</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, Age 54</h4>
                        <p>5 years post-menopause | BMI 19.5 | Distance Runner</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Sarah presented with a minor wrist fracture after a low-impact trip. She considered herself "very fit" due to daily running and a "clean" diet (low calorie, vegan). She had never had a DXA scan.</p>
                <p><strong>Screening Results:</strong> DXA showed a T-score of -2.6 at the femoral neck and -2.2 at the lumbar spine. Despite her exercise, her low BMI and early menopause (age 46) were significant risk factors.</p>
                <p><strong>Intervention:</strong> Introduction of heavy resistance training (2x weekly), Vitamin D3/K2 supplementation, and increasing protein intake to 1.4g/kg. Referral for Hormone Replacement Therapy (HRT) evaluation.</p>
                <p><strong>Outcome:</strong> 18-month follow-up DXA showed stabilization of BMD (T-score -2.5) and significant improvements in functional strength markers.</p>
            </div>
        </div>

        <h2 id="section5">Interpreting T-Scores</h2>
        <p>When reviewing a client's DXA report, you will see two primary scores: the T-score and the Z-score. For post-menopausal women, the <span class="highlight">T-score is the diagnostic metric</span>.</p>

        <div class="principle-card">
            <p class="principle-title">WHO Diagnostic Criteria (T-Score)</p>
            <ul class="content-list">
                <li><strong>Normal:</strong> -1.0 or higher.</li>
                <li><strong>Osteopenia (Low Bone Mass):</strong> Between -1.0 and -2.5.</li>
                <li><strong>Osteoporosis:</strong> -2.5 or lower.</li>
                <li><strong>Severe Osteoporosis:</strong> -2.5 or lower with one or more fragility fractures.</li>
            </ul>
        </div>

        <div class="alert-box info">
            <p class="alert-label">T-Score vs. Z-Score</p>
            <p>The <strong>T-score</strong> compares the client to a young adult (peak bone mass). The <strong>Z-score</strong> compares the client to people of their own age/ethnicity. If the Z-score is significantly low (below -2.0), it suggests that something <em>other</em> than menopause (like hyperthyroidism or malabsorption) is causing the bone loss.</p>
        </div>

        <h2 id="section6">FRAX: Assessing Clinical Risk</h2>
        <p>Bone density is only one part of the story. <span class="highlight">Bone quality</span> (micro-architecture) is just as important as density. To bridge this gap, clinicians use the <strong>FRAX (Fracture Risk Assessment Tool)</strong>.</p>
        
        <p>FRAX is an algorithm developed by the University of Sheffield that calculates the 10-year probability of a major osteoporotic fracture. It considers factors DXA cannot see:</p>
        <ul class="content-list">
            <li>Age and BMI</li>
            <li>Previous fractures (especially after age 50)</li>
            <li>Parental history of hip fracture</li>
            <li>Current smoking and alcohol intake (3+ units/day)</li>
            <li>Glucocorticoid use (e.g., Prednisone)</li>
            <li>Rheumatoid arthritis and secondary osteoporosis</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why does a drop in estrogen lead to an increase in bone resorption?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Estrogen normally stimulates Osteoprotegerin (OPG), which acts as a "decoy" to stop RANKL from activating osteoclasts. When estrogen drops, OPG levels fall, allowing RANKL to bind freely to osteoclasts, extending their lifespan and increasing their "bone-chewing" activity.</div>
            </div>
            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">A 58-year-old client shows a T-score of -1.8 at the hip. How would you classify this?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">This is classified as Osteopenia (Low Bone Mass), as it falls between -1.0 and -2.5. This is a critical "yellow light" period where lifestyle interventions can prevent progression to osteoporosis.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The first 5 years of menopause are the "high-risk" window for rapid bone loss (up to 20% of total lifetime loss).</li>
                <li>Estrogen is the primary regulator of the RANKL/OPG pathway; its loss leads to "uncoupled" bone remodeling.</li>
                <li>DXA is the gold standard for screening, using the T-score as the primary diagnostic tool for post-menopausal women.</li>
                <li>A T-score of -2.5 or lower defines osteoporosis, but fracture risk is also heavily influenced by clinical factors (FRAX).</li>
                <li>Bone density screening should ideally begin at the onset of menopause for women with high-risk factors (low BMI, smoking, early menopause).</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <p>1. Khosla S. et al. (2020). "The Pathogenesis of Osteoporosis." <i>Journal of Clinical Investigation.</i></p>
            <p>2. Eastell R. et al. (2019). "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline." <i>Journal of Clinical Endocrinology & Metabolism.</i></p>
            <p>3. International Osteoporosis Foundation (2022). "Global Statistics on Osteoporosis and Fragility Fractures."</p>
            <p>4. Ji M.X. et al. (2015). "Signaling pathways in osteoclast differentiation and function." <i>Molecular Medicine Reports.</i></p>
            <p>5. Kanis J.A. et al. (2019). "European guidance for the diagnosis and management of osteoporosis in postmenopausal women." <i>Osteoporosis International.</i></p>
            <p>6. Shieh A. et al. (2022). "Bone loss across the menopausal transition." <i>Endocrine Reviews.</i></p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Certified Menopause Support Coach | Module 2: Vascular & Bone Integrity</p>
        </footer>
    </div>
</body>

</html>